Narendra Krishnani
Overview
Explore the profile of Narendra Krishnani including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
997
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mishra A, Mishra S, Sharanappa V, Krishnani N, Kumari N, Agarwal G
Indian J Surg Oncol
. 2024 May;
15(2):250-257.
PMID: 38741650
Molecular sub-characterization of triple-negative breast cancer (TNBC) has great therapeutic and possibly prognostic implications. The primary aim of this study was to investigate the incidence of luminal androgen receptor (LAR) ...
2.
Agarwal A, George N, Kumari N, Krishnani N, Mishra P, Gupta S
Indian J Pathol Microbiol
. 2024 Apr;
67(4):733-738.
PMID: 38563686
Introduction: Poorly differentiated thyroid cancer (PDTC) remains a challenge not only for pathologists and surgeons because of the difficulties associated with the diagnostic process and the compelling need for difficult...
3.
Shukla P, Mishra K, Shukla R, Vishwakarma R, Kumari N, Krishnani N, et al.
J Cancer Res Ther
. 2024 Mar;
20(1):349-357.
PMID: 38554345
Aim: Gallbladder cancer (GBC) is usually diagnosed in advanced stages with poor survival. The molecular mechanisms of GBC still remain unexplored. Several angiogenesis factors play a pivotal role in tumor...
4.
Baranwal H, Mishra S, Kumari N, Singh S, Krishnani N, Nath A, et al.
Indian J Pathol Microbiol
. 2024 Feb;
67(3):502-509.
PMID: 38391370
Introduction: Non-small cell lung cancer (NSCLC) is the leading cause of mortality globally. Early imaging detection modalities are associated with high false-positive rates and radiation exposure. A non-invasive biomarker can...
5.
Prasad P, Singh A, Singh A, Mishra P, Krishnani N
Indian J Pathol Microbiol
. 2024 Feb;
67(1):96-101.
PMID: 38358196
Background: Budd-Chiari syndrome (BCS) requires a constellation of clinical, imaging, and histological findings for diagnosis. Liver biopsy serves as a tool for confirming the diagnosis, even though the histological characteristics...
6.
Malakar S, Mathur A, Mishra P, Radha P, Kulkarni A, Krishnani N, et al.
J Clin Exp Hepatol
. 2023 Nov;
13(6):1156-1158.
PMID: 37975054
No abstract available.
7.
Paturu R, Lingaiah R, Kumari N, Singh S, Krishnani N, Srivastava S, et al.
Asian Pac J Cancer Prev
. 2023 Oct;
24(10):3467-3475.
PMID: 37898852
Objectives: Testing for EGFR, ALK, ROS1 and MET alterations in paired tissue and plasma samples of treatment-naïve patients of NSCLC and correlating their status with overall survival. Materials And Methods:...
8.
Siddiqui S, Kumari N, Mishra S, Radha P, Mohindra S, Singh R, et al.
Int J Surg Pathol
. 2023 Jun;
32(2):263-272.
PMID: 37291997
Introduction: Ampullary adenocarcinoma is a rare neoplasm often treated by the complex Whipple's procedure. Several histological factors predict poor prognosis including pancreatobiliary morphology, presence of lymphovascular, perineural invasion and local...
9.
Prasad P, Gupta A, Nath A, Hashim Z, Gupta M, Krishnani N, et al.
Sarcoidosis Vasc Diffuse Lung Dis
. 2023 Mar;
40(1):e2023004.
PMID: 36975056
Background And Aim: Diffuse alveolar hemorrhage (DAH) is a life-threatening condition due to the extravasation of blood in the alveoli, resulting in hypoxemia and even acute respiratory distress syndrome. This...
10.
Agarwal G, Chanthar K, Katiyar S, Kumari N, Krishnani N, Sabaretnam M, et al.
World J Surg
. 2023 Feb;
47(5):1238-1246.
PMID: 36735048
Introduction: Tumor-infiltrating lymphocytes (TILs) are gaining recognition as an important immunological biomarker with therapeutic potential in breast cancer. In this cohort study conducted on patients with advanced breast cancer treated...